TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | -0 | -3 | -4 | 2 | -11 | 13 | -1 |
| S | %wins | 67 | 67 | 67 | 33 | 100 | 67 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/3/05 11:22 | 6/1/05 | DDD | Scolr Pharma, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Howard David T | WA | D | S | -88 | 3.52 | 5 | -25 | -100 | 0 | D | 258 | 89 | 27 | 8 | 8 | 11 | -5 | -4 | -1 | 7 | 17 | 9 | -14 | -6 | |
4/11/05 12:35 | 4/7/05 | DDD | Scolr Pharma, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Howard David T | WA | D | S.m | -126 | 3.87 | 3 | -33 | -100 | 0 | D | 282 | 83 | 92 | 4 | 7 | 15 | 10 | 5 | 1 | -14 | -23 | 10 | -7 | 0 | |
4/28/04 17:07 | 4/26/04 | DDD | Scolr Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Howard David T | WA | D | S.d | -650 | 3.25 | 1 | -200 | -100 | 0 | D | -1 | 140 | 39 | -3 | 1 | 11 | 3 | 8 | -1 | -3 | -7 | -12 | -13 | 46 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |